scispace - formally typeset
R

Robert M. Cohen

Researcher at University of Cincinnati Academic Health Center

Publications -  677
Citations -  41006

Robert M. Cohen is an academic researcher from University of Cincinnati Academic Health Center. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 77, co-authored 636 publications receiving 34058 citations. Previous affiliations of Robert M. Cohen include University of Rochester Medical Center & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

A global reference for human genetic variation.

Adam Auton, +517 more
- 01 Oct 2015 - 
TL;DR: The 1000 Genomes Project set out to provide a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations, and has reconstructed the genomes of 2,504 individuals from 26 populations using a combination of low-coverage whole-generation sequencing, deep exome sequencing, and dense microarray genotyping.

A global reference for human genetic variation

Adam Auton, +479 more
TL;DR: The 1000 Genomes Project as mentioned in this paper provided a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations, and reported the completion of the project, having reconstructed the genomes of 2,504 individuals from 26 populations using a combination of low-coverage whole genome sequencing, deep exome sequencing and dense microarray genotyping.
Journal ArticleDOI

Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man

TL;DR: Disruption of the estrogen receptor in humans need not be lethal and is important for bone maturation and mineralization in men as well as women.
Journal ArticleDOI

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

TL;DR: The findings suggest that the 2 measures, CSF beta-amyloid and tau, are biological markers of AD pathophysiology and may have a potential clinical utility as biomarkers of disease.